📰 Safety Data Expected News
Safety Data Expected News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Safety Data Expected. Real-time updates on events, politics, business and more.
March 15, 2022
/PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI) is a clinical-stage biopharmaceutical company developing an investigational therapy Haduvio™...
March 15, 2022
Previously Announced Statistically Significant Interim Analysis Established Proof of Concept Efficacy and Safety Data Expected on the Full Set of Subjects in Third Quarter 2022 NEW HAVEN, Conn.,... | March 15, 2022
March 15, 2022
/PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI) is a clinical-stage biopharmaceutical company developing an investigational therapy Haduvio™...